TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
5.49
-0.06 (-0.99%)
Dec 3, 2024, 2:09 PM EST - Market open
TuHURA Biosciences Employees
TuHURA Biosciences had 1 employees as of December 31, 2023.
Employees
1
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$19,333,782
Market Cap
230.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1 | - | - |
HURA News
- 8 days ago - TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update - Accesswire
- 5 weeks ago - TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC - Accesswire
- 6 weeks ago - TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event - Accesswire
- 6 weeks ago - TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics - Accesswire
- 6 weeks ago - Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024 - PRNewsWire
- 6 weeks ago - Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences - PRNewsWire
- 6 weeks ago - Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 - PRNewsWire
- 7 weeks ago - Kintara Therapeutics Announces Record Date for CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 - PRNewsWire